| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.034 | 0.8 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |